P3 Health Partners Inc. (PIII)
NASDAQ: PIII · IEX Real-Time Price · USD
0.500
-0.013 (-2.48%)
At close: Apr 24, 2024, 4:00 PM
0.512
+0.012 (2.40%)
After-hours: Apr 24, 2024, 4:21 PM EDT
P3 Health Partners Market Cap
P3 Health Partners has a market cap or net worth of $158.05 million as of April 24, 2024. Its market cap has decreased by -42.59% in one year.
Market Cap
158.05M
Enterprise Value
237.63M
1-Year Change
-42.59%
Ranking
Category
Stock Price
$0.50
Market Cap Chart
Since February 10, 2021, P3 Health Partners's market cap has decreased from $361.80M to $158.05M, a decrease of -56.32%. That is a compound annual growth rate of -22.80%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 162.10M | -1.70% |
Apr 22, 2024 | 164.90M | 3.19% |
Apr 19, 2024 | 159.80M | 0.95% |
Apr 18, 2024 | 158.30M | 0.19% |
Apr 17, 2024 | 158.00M | 5.97% |
Apr 16, 2024 | 149.10M | -4.24% |
Apr 15, 2024 | 155.70M | -15.75% |
Apr 12, 2024 | 184.80M | -1.70% |
Apr 11, 2024 | 188.00M | -5.67% |
Apr 10, 2024 | 199.30M | -11.03% |
Apr 9, 2024 | 224.00M | -9.79% |
Apr 8, 2024 | 248.30M | -2.59% |
Apr 5, 2024 | 254.90M | -1.47% |
Apr 4, 2024 | 258.70M | 3.65% |
Apr 3, 2024 | 249.60M | -0.24% |
Apr 2, 2024 | 250.20M | -10.52% |
Apr 1, 2024 | 279.60M | -14.07% |
Mar 28, 2024 | 325.40M | 1.88% |
Mar 27, 2024 | 319.40M | 10.63% |
Mar 26, 2024 | 288.70M | -9.61% |
Mar 25, 2024 | 319.40M | 3.17% |
Mar 22, 2024 | 309.60M | -7.58% |
Mar 21, 2024 | 335.00M | 15.68% |
Mar 20, 2024 | 289.60M | -5.61% |
Mar 19, 2024 | 306.80M | 1.32% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
American Well | 161.85M |
Butterfly Network | 161.09M |
ProQR Therapeutics | 160.83M |
Harvard Bioscience | 160.58M |
Adicet Bio | 160.23M |
Cybin | 158.99M |
Capricor Therapeutics | 157.83M |
Inogen | 157.46M |